We’re doing some maintenance between 14:00 (2:00 PM) CEST and 22:00 (10:00 PM) CEST on Saturday, April 11, 2026. There will be interruptions to the following services during this time: authentication, funding and trading systems. Things will be back to normal as soon as the maintenance window has ended. We apologise for the inconvenience.

Swedish Orphan Biovitrum AB

Swedish Orphan Biovitrum AB (Sobi) is a leading biopharmaceutical company that specializes in developing and delivering innovative therapies for rare diseases. Focusing on hemophilia, inflammation, and genetic and metabolic diseases, Sobi is dedicated to improving the lives of patients worldwide. The company's portfolio includes a range of treatments, from plasma-derived and recombinant therapies to gene therapies and small molecules. Operating in over 30 countries, Sobi has a strong presence in Europe, North America, and the Middle East. With a team of experts and a passion for innovation, Sobi is at the forefront of the rare disease community, working tirelessly to bring hope and healing to patients and families affected by these challenging conditions.

Instrument specification for Swedish Orphan Biovitrum AB

Name
Minimum order value
Description
Maximum order value
Transaction Step
Type
Trading Hours
Contract size / 1 lot
Deposit required
Value of 1 pip
Financial leverage
Minimal step
Long swap (daily)
Short sale NO
Short swap (daily)
Distance SL and TP 0
3-day swap (date)

Start trading now with fast account opening.

Sign-up now to trade the most active markets

Open account
Boasting over 20 years in the markets, leading analysis tools and thousands of satisfied clients, OANDA is proud to be an award-winning broker.
Get access to the most active of global markets with thousands of trading instruments at your fingertips, as well leading technical tools to assist in your analysis.
Trade without unnecessary costs and total pricing transparency - OANDA offers zero-commission on major instruments, transparent pricing.
Scroll to top